What the trials show about stopping
The clearest evidence comes from the STEP 1 trial extension. Participants lost an average of about 17% of their body weight over 68 weeks on semaglutide 2.4 mg. Treatment then stopped, and over the following year, they regained roughly two-thirds of what they had lost. Cardiometabolic improvements (blood pressure, blood sugar markers) drifted back the same way.
The SELECT cardiovascular trial told the flip side of the story: for people who stay on treatment, benefits persist, which is why NICE framed semaglutide for cardiovascular risk reduction (TA1152) as ongoing therapy. The message from both directions is the same: Wegovy works while you take it, and maintenance after it needs a plan.
The NHS two-year limit, and what it means for you
Under NICE TA875, NHS-funded semaglutide for weight management is limited to a maximum of two years within a specialist service. Whatever your views on that policy, it means every NHS Wegovy patient needs an exit strategy from day one. Private patients have more flexibility (many continue longer, taper, or use lower maintenance doses) but the biology is identical either way: plan maintenance before you need it.
Why the weight comes back
- Appetite rebound. The GLP-1 signal that quietened food noise disappears within weeks of the last dose.
- Metabolic adaptation. A lighter body burns fewer calories, and if you lost muscle during weight loss, it burns fewer still.
- The environment didn't change. The medicine was overriding your food environment; without it, old defaults return unless new defaults exist.
The maintenance playbook
1. Defend muscle like it matters, because it does
Lean mass is your calorie-burning engine. Resistance training two or three times weekly, plus adequate daily protein (get your number from our protein calculator), is the closest thing maintenance has to a cheat code.
2. Keep the "protein first" eating pattern
The habit that served you on treatment (protein at every meal, eaten first) continues doing appetite control after the medicine stops. It is the highest-satiety, lowest-effort lever available.
3. Step down rather than stop dead
Going from 2.4 mg (or 7.2 mg) to zero overnight is the hardest possible transition. Many prescribers support dose step-downs or extended intervals to let habits take over gradually. Discuss this months before your planned stop, especially if you are approaching the NHS two-year limit, where the specialist service should be planning the transition with you.
4. Structure beats motivation
Fixed meal times, repeatable default meals, planned treats. Motivation is a finite resource; structure runs on autopilot. Our Wegovy nutrition guide translates this into actual meals.
5. Monitor and respond early
Weekly weigh-ins with a pre-agreed action threshold (2 to 3 kg above your floor) turn "suddenly I'd regained a stone" into "I caught it at 2 kg". Tracking apps make the monitoring almost effortless.
6. Treat restarting as medicine, not failure
Obesity is a chronic, relapsing condition. Restarting semaglutide (or switching to tirzepatide) after regain is a clinical option, not a character verdict. The evidence is unambiguous that ongoing treatment maintains benefit; the question is simply what you and your prescriber decide is sustainable.
The people who keep weight off after Wegovy treat the injection as scaffolding, not the building. Protein, training, structure and monitoring are the building. If long-term cost is part of your planning, iGovy.co.uk's manually verified provider list helps you compare sustainable options. For the injection or the new tablet.
Frequently asked questions
Do you regain weight after stopping Wegovy? +
On average, yes. The STEP 1 extension found people regained about two-thirds of lost weight within a year of stopping. But the range is wide, and people who maintain protein intake, resistance training and structured eating do markedly better than average.
Why does the NHS limit Wegovy to two years? +
NICE TA875 recommended semaglutide for a maximum of two years within specialist weight management services, based on the evidence and cost-effectiveness modelling available in 2023. Private treatment is not bound by this limit.
Is tapering off Wegovy better than stopping suddenly? +
Many clinicians prefer gradual dose reduction so appetite and habits adjust progressively. There is no licensed taper schedule. Agree the approach with your prescriber well before your intended stop date.
What is the best way to avoid regain after semaglutide? +
The evidence-supported combination: resistance training to preserve muscle, high daily protein, structured meal patterns, weekly weight monitoring with an early-response plan, and willingness to restart pharmacotherapy if regain continues despite those measures.
Can I switch from Wegovy to Mounjaro for maintenance? +
That is a prescriber decision. Some people switch to tirzepatide for additional loss or different tolerability. Doses do not map one-to-one between the medicines, so the switch should be clinically supervised.
References & official sources
Show all 5 cited sources, with study authors +
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: STEP 1 trial extension. Diabetes Obes Metab 2022: dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021: www.nejm.org/doi/full/10.1056/NEJMoa2032183
- NICE TA875. Semaglutide for managing overweight and obesity: www.nice.org.uk/guidance/ta875
- NICE TA1152. Semaglutide for reducing cardiovascular risk: www.nice.org.uk/guidance/ta1152
- NICE NG246. Overweight and obesity management: www.nice.org.uk/guidance/ng246